Oruka Therapeutics names Todd Edwards chief commercial officer
ORKA•Todd Edwards appointed chief commercial officer
Oruka Therapeutics named Todd Edwards chief commercial officer, effective Aug. 24, 2026.
Edwards joins from Arcutis Biotherapeutics, where he served as executive vice president and chief commercial officer overseeing the ZORYVE franchise.
He previously led immunology as group vice president and business head at Incyte.
Earlier roles include senior vice president posts at UCB, with additional senior positions at AbbVie and TAP Pharmaceuticals.




